Locations:
Min Investment:
Max Investment:
Target Investment:
2003
Involved in assessing new venture opportunities and assisting management in growing life science based companies.
2018
2018
1986 - 2022
1986 - 2022
Provide advice and counsel to the Dean of the College of Engineering at the University of Tennessee on a wide range of academic, financial and strategic issues.
2004 - 2020
2004 - 2020
Chairman of Mercy Multiplied, International
2001 - 2016
2001 - 2016
Served as an independent director for Corcept Therapeutics, Inc., a publicly traded company developing medicines for people with Cushings Syndrome and cancer.
1998 - 2015
1998 - 2015
Founder and Chairman of the Board from 1998 until 2011.
2005 - 2015
2005 - 2015
Former member of a strategy board for Elanco that provided independent advice and counsel to Elanco Products Company a wholly owned division of Eli Lilly & Co. Elanco is focused on developing, manufacturing, and marketing products to serve the animal health and companion animal markets.
1998 - 2009
1998 - 2009
Provided overall Board leadership for Amylin Pharmaceuticals, Inc. a publically traded company developing, manufacturing and marketing medicines for people with diabetes.
1998 - 2003
As CEO of Amylin form 1998 to 2003, I was directly involved in leading the company through a challenging time which started with clinical trials that did not meet expectations. Eventually the company was able to complete a successful development plan which led to approval and marketing of three products to treat people with diabetes.
1988 - 2004
1988 - 2004
Provided overall trustee advice, counsel and support for a theological seminary focused on educating men and women to serve as pastors in protestant churches.
1965 - 1993
1965 - 1993
1965 - 1993
Responsible for global operations of Eli Lilly & Co. including manufacturing, production planning, purchasing, engineering, quality assurance, facilities, new product development and launch preparation.